News

2017

 

May 2017:

  • Sebastian Kobold und Stefan Endres: Antrag Onkattract beim Bundesministerium für Bildung und Forschung, Projektträger Jülich wurde mit 1.202.588,40 Euro bewilligt

February 2017:

  • Adrian Gottschlich was selected for the "Studienstiftung des deutschen Volkes"
  • Severin Jacobi was selected for a Jose-Carreras-Foundation doctoral student fellowship
  • Angelina Krächan was selected for a Mildreed-Scheel-Foundation doctoral
    student fellowship
  • PD Dr. Sebastian Kobold was awarded the Hugo-Wilhelm-von Ziemssen-Award
    for medical research

January 2017:

  • PD Dr. med. Sebastian Kobold and PD Dr. med. Stefan Endres: New research cooperation with TCR2 Therapeutics Inc. located in Cambridge, USA to improve T cell-based therapy (DE/EN)

 

2016

 

October 2016:

  • PD Dr. med. Sebastian Kobold received the Vincenz-Czerny Award 2016 by the German Society for Hematology and Medical Oncology

September 2016:

  • Max Knott and Moritz Schmidbauer were selected into the "MeCuM StEP - Studierende Exzellenz Programm" LMU

August 2016:

  • Cornelia Ochs was awarded funding by the CIPSMwomen program


July 2016:

  • Stefan Stoiber was awarded funding by the LMUexcellent student research program
  • Our manuscript "Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases" was accepted for publication in BMC Cancer, congratulations to Amanda and her team!
  • AG Anz was awarded funding by the Wilhelm-Sander-Stiftung

June 2016:

  • Dr. Felicitas Rataj was awarded funding by the Friedrich Baur Foundation
  • PD Dr. Sebastian Kobold was awarded funding by the LMUExcellent program
  • The Clinician Scientist Program Cancer Immunotherapy (CSP Munich) coordinated by Prof. Marion Subklewe has been selected for funding by the Else Kröner Fresenius Stiftung. PD Dr. Sebastian Kobold is one of the PI of the program. Congratulations!

May 2016:

  • Our manuscript "A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice" was accepted for publication in Oncoimmunology. Congratulations to Gabi and her team!

April 2016:

  • PD Dr. med. Sebastian Kobold receives the BMS-Melanoma Research Alliance Young Investigator Award

  • PD Dr. med. Sebastian Kobold is awarded funding by the Verein zur Förderung von Wissenschaft und Forschung an der Medizinischen Fakultät der Ludwig-Maximilians-Universität München

  • Fabian Kraus is awarded a travel grant to the CIMT meeting 2016 in Mainz by the Studienstiftung des Deutschen Volkes


March 2016:

  • Dr. Felicitas Rataj is awarded funding from the CIPSM Gender Program

  • Stefanie Lesch is awarded funding from the CIPSM Gender Program

  • Clara Karches is awarded funding from the CIPSM Gender Program


January 2016:

  • PD Dr. Sebastian Kobold is selected for the career advancement award of the Ernst Jung Stiftung